MED23-ANO2 Fusion FISH Probe
The MED23-ANO2 Fusion FISH Probe is used to confirm a fusion of the MED23 and ANO2 genes. The fusion of the MED23 and ANO2 genes has been associated with Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MED23-ANO2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MED23-ANO2-20-AQAQ | 20 (40 μL) | 200 μL |
|
MED23 Gene Summary
The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. This protein also acts as a metastasis suppressor. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2012]
Gene Name: Mediator Complex Subunit 23
Chromosome: CHR6: 131895105 -131949363
Locus: 6q23.2
ANO2 Gene Summary
ANO2 belongs to a family of calcium-activated chloride channels (CaCCs) (reviewed by Hartzell et al., 2009 [PubMed 19015192]).[supplied by OMIM, Jan 2011]
Gene Name: Anoctamin 2
Chromosome: CHR12: 5671816 -6055398
Locus: 12p13.31
Gene Diseases
The MED23 ANO2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|